Format
Items per page
Sort by

Send to:

Choose Destination

Results: 1 to 20 of 144

1.

Bone metabolism, growth rate and pubertal development in children with chronic myeloid leukemia treated with imatinib during puberty.

Giona F, Mariani S, Gnessi L, Moleti ML, Rea M, De Vellis A, Marzella D, Testi AM, FoĆ  R.

Haematologica. 2013 Mar;98(3):e25-7. doi: 10.3324/haematol.2012.067447. Epub 2012 Sep 14. No abstract available.

PMID:
22983586
[PubMed - indexed for MEDLINE]
Free PMC Article
2.

[Additional chromosomal abnormalities in dynamic of target therapy for chronic myeloid leukemia in children and adolescents].

Andreeva SV, Drozdova VD.

Lik Sprava. 2014 Jan-Feb;(1-2):55-9. Russian.

PMID:
24908961
[PubMed - indexed for MEDLINE]
3.

Bone metabolism during long-term treatment with imatinib.

O'Sullivan S, Horne A, Wattie D, Porteous F, Gamble G, Browett P, Grey A.

Leuk Lymphoma. 2013 Aug;54(8):1783-5. doi: 10.3109/10428194.2012.760734. Epub 2013 Jan 24. No abstract available.

PMID:
23278638
[PubMed - indexed for MEDLINE]
4.

Changes in bone metabolic parameters in children with chronic myeloid leukemia on imatinib treatment.

Jaeger BA, Tauer JT, Ulmer A, Kuhlisch E, Roth HJ, Suttorp M.

Med Sci Monit. 2012 Dec;18(12):CR721-8.

PMID:
23197234
[PubMed - indexed for MEDLINE]
Free PMC Article
5.

Low bone density and decreased inhibin-B/FSH ratio in a boy treated with imatinib during puberty.

Mariani S, Giona F, Basciani S, Brama M, Gnessi L.

Lancet. 2008 Jul 12;372(9633):111-2. doi: 10.1016/S0140-6736(08)61023-5. No abstract available.

PMID:
18620939
[PubMed - indexed for MEDLINE]
6.

Periungual pyogenic granuloma following imatinib therapy in a patient with chronic myelogenous leukemia.

Dika E, Barisani A, Vaccari S, Fanti PA, Ismaili A, Patrizi A.

J Drugs Dermatol. 2013 May;12(5):512-3. No abstract available.

PMID:
23652942
[PubMed - indexed for MEDLINE]
7.

Nilotinib is associated with a reduced incidence of BCR-ABL mutations vs imatinib in patients with newly diagnosed chronic myeloid leukemia in chronic phase.

Hochhaus A, Saglio G, Larson RA, Kim DW, Etienne G, Rosti G, De Souza C, Kurokawa M, Kalaycio ME, Hoenekopp A, Fan X, Shou Y, Kantarjian HM, Hughes TP.

Blood. 2013 May 2;121(18):3703-8. doi: 10.1182/blood-2012-04-423418. Epub 2013 Mar 15.

PMID:
23502220
[PubMed - indexed for MEDLINE]
Free Article
8.

A patient of chronic myelogenous leukemia developing painful rash on feet.

Kumar P, Das NK, Sil A, Chakrabarti P.

J Postgrad Med. 2012 Oct-Dec;58(4):331-4. doi: 10.4103/0022-3859.105489. No abstract available.

PMID:
23298941
[PubMed - indexed for MEDLINE]
Free Article
9.

Distinct impact of imatinib on growth at prepubertal and pubertal ages of children with chronic myeloid leukemia.

Shima H, Tokuyama M, Tanizawa A, Tono C, Hamamoto K, Muramatsu H, Watanabe A, Hotta N, Ito M, Kurosawa H, Kato K, Tsurusawa M, Horibe K, Shimada H.

J Pediatr. 2011 Oct;159(4):676-81. doi: 10.1016/j.jpeds.2011.03.046. Epub 2011 May 17.

PMID:
21592517
[PubMed - indexed for MEDLINE]
10.

Hyperpigmentation of the hard palate associated with imatinib therapy for chronic myeloid leukemia with a genetic variation in the proto-oncogene c-KIT.

Khoo TL, Catalano A, Supple S, Chong L, Yeoh SC, Yeung S, Iland H.

Leuk Lymphoma. 2013 Jan;54(1):186-8. doi: 10.3109/10428194.2012.702904. Epub 2012 Aug 14. No abstract available.

PMID:
22712835
[PubMed - indexed for MEDLINE]
11.

Management of the new patient with CML in chronic phase.

Marin D.

Curr Hematol Malig Rep. 2013 Mar;8(1):37-42. doi: 10.1007/s11899-012-0151-0. Review.

PMID:
23381448
[PubMed - indexed for MEDLINE]
12.

Imatinib-induced postoperative periorbital purpura: GASP (Gleevec-Associated Surgical Purpura) in a woman with imatinib-treated chronic myelogenous leukemia.

Anzalone CL, Cohen PR, Kurzrock R, Cortes JE.

Dermatol Online J. 2014 Jan 15;20(1):21242.

PMID:
24456946
[PubMed - indexed for MEDLINE]
Free Article
13.

Does early imatinib-induced myelosuppression predict hematologic responses in patients with advanced-phase chronic myeloid leukemia?

Cashen A, DiPersio JF, Khoury H.

J Clin Oncol. 2003 Nov 15;21(22):4255-6. No abstract available.

PMID:
14615462
[PubMed - indexed for MEDLINE]
14.

[Chronic myelogenous leukemia: management of treatment-related adverse events].

Takahashi N.

Rinsho Ketsueki. 2012 Oct;53(10):1581-8. Review. Japanese. No abstract available.

PMID:
23037730
[PubMed - indexed for MEDLINE]
15.

Vocal fold hemorrhage in a CML patient after Glivec treatment.

Shim HS, Woo SH.

Acta Oncol. 2013 May;52(4):866-8. doi: 10.3109/0284186X.2012.728715. Epub 2012 Nov 15. No abstract available.

PMID:
23153030
[PubMed - indexed for MEDLINE]
16.

Dasatinib in children and adolescents with relapsed or refractory leukemia: results of the CA180-018 phase I dose-escalation study of the Innovative Therapies for Children with Cancer Consortium.

Zwaan CM, Rizzari C, Mechinaud F, Lancaster DL, Lehrnbecher T, van der Velden VH, Beverloo BB, den Boer ML, Pieters R, Reinhardt D, Dworzak M, Rosenberg J, Manos G, Agrawal S, Strauss L, Baruchel A, Kearns PR.

J Clin Oncol. 2013 Jul 1;31(19):2460-8. doi: 10.1200/JCO.2012.46.8280. Epub 2013 May 28.

PMID:
23715577
[PubMed - indexed for MEDLINE]
Free Article
17.

Nilotinib population pharmacokinetics and exposure-response analysis in patients with imatinib-resistant or -intolerant chronic myeloid leukemia.

Giles FJ, Yin OQ, Sallas WM, le Coutre PD, Woodman RC, Ottmann OG, Baccarani M, Kantarjian HM.

Eur J Clin Pharmacol. 2013 Apr;69(4):813-23. doi: 10.1007/s00228-012-1385-4. Epub 2012 Oct 5.

PMID:
23052406
[PubMed - indexed for MEDLINE]
18.

Clinical characteristics and hematologic responses to Imatinib in patients with chronic phase myeloid leukemia (CML) at Cipto Mangunkusumo Hospital.

Reksodiputro AH, Syafei S, Prayogo N, Karsono B, Rinaldi I, Rajabto W, Mulansari NA.

Acta Med Indones. 2010 Jan;42(1):2-5.

PMID:
20305324
[PubMed - indexed for MEDLINE]
Free Article
19.

Imatinib for chronic myeloid leukemia: the impact of its effectiveness and long-term side effects.

Smith BD.

J Natl Cancer Inst. 2011 Apr 6;103(7):527-9. doi: 10.1093/jnci/djr073. Epub 2011 Mar 21. No abstract available.

PMID:
21422404
[PubMed - indexed for MEDLINE]
Free Article
20.

Imatinib-induced aplastic anemia in a patient with chronic myeloid leukemia.

Mabed M, Elhefni AM, Damnhouri G.

Leuk Lymphoma. 2012 Nov;53(11):2310-1. doi: 10.3109/10428194.2012.680452. Epub 2012 Apr 30. No abstract available.

PMID:
22462614
[PubMed - indexed for MEDLINE]
Format
Items per page
Sort by

Send to:

Choose Destination

Supplemental Content

Write to the Help Desk